• Pediatrics, Pediatric Surgery
• Gene Therapy
• Controversies and Debates
• Medical Retina: Diabetic Macular Edema and Diabetic Retinopathy
• RETINAWS
• Uveitis
• First-time Presentations of Clinical Trials and Late Breakers

After completing this activity, the participant should be better able to:

• Review the latest clinical trial data and treatments in clinical trials relevant to retinal disorders
• Identify new technologies that may reduce treatment burden for patients with retinal vascular disease
• Evaluate new imaging technologies that can improve retinal disease detection and better assess patient responses to therapy
• Identify advantages and disadvantages of combination therapies for the treatment of neovascular age-related macular degeneration (AMD)
• Explain the mechanism of action, ongoing clinical trial designs, and advantages and disadvantages of new therapies being developed for the treatment of diabetic retinopathy (DR)
• Assess novel management strategies in treating patients with diabetic retinopathy
• Describe the latest clinical trial data, patient outcomes, and emerging treatments for diabetic macular edema (DME)
• Recall the latest clinical trial data and management strategies for retinal vein occlusion
• Recognize side effects of commonly used uveitis treatments, and optimize management of patients who develop these side effects
• Summarize key clinical study findings for new treatment options being developed for the treatment of uveitis